177 related articles for article (PubMed ID: 21914223)
1. In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.
Kato TA; Tsuda A; Uesaka M; Fujimori A; Kamada T; Tsujii H; Okayasu R
Radiat Oncol; 2011 Sep; 6():116. PubMed ID: 21914223
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human chordoma cell-kill for 290 MeV/n carbon ions versus 70 MeV protons in vitro.
Fujisawa H; Genik PC; Kitamura H; Fujimori A; Uesaka M; Kato TA
Radiat Oncol; 2013 Apr; 8():91. PubMed ID: 23587329
[TBL] [Abstract][Full Text] [Related]
3. The effects of chemotherapeutic agents on differentiated chordoma cells.
Bayrak OF; Aydemir E; Gulluoglu S; Sahin F; Sevli S; Yalvac ME; Acar H; Ozen M
J Neurosurg Spine; 2011 Dec; 15(6):620-4. PubMed ID: 21905773
[TBL] [Abstract][Full Text] [Related]
4. Identification of repurposed small molecule drugs for chordoma therapy.
Xia M; Huang R; Sakamuru S; Alcorta D; Cho MH; Lee DH; Park DM; Kelley MJ; Sommer J; Austin CP
Cancer Biol Ther; 2013 Jul; 14(7):638-47. PubMed ID: 23792643
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.
Harryman WL; Gard JMC; Pond KW; Simpson SJ; Heppner LH; Hernandez-Cortes D; Little AS; Eschbacher JM; Cress AE
Neoplasia; 2017 Nov; 19(11):919-927. PubMed ID: 28954241
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
Kim JY; Lee J; Koh JS; Park MJ; Chang UK
J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
[TBL] [Abstract][Full Text] [Related]
8. Chordoma-derived cell line U-CH1-N recapitulates the biological properties of notochordal nucleus pulposus cells.
Fujita N; Suzuki S; Watanabe K; Ishii K; Watanabe R; Shimoda M; Takubo K; Tsuji T; Toyama Y; Miyamoto T; Horiuchi K; Nakamura M; Matsumoto M
J Orthop Res; 2016 Aug; 34(8):1341-50. PubMed ID: 27248133
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
[TBL] [Abstract][Full Text] [Related]
10. Differential Radiosensitivity of Uveal Melanoma Cell Lines After X-rays or Carbon Ions Radiation.
Calipel A; Lux AL; Guérin S; Lefaix JL; Laurent C; Bernaudin M; Mouriaux F
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3085-94. PubMed ID: 26024093
[TBL] [Abstract][Full Text] [Related]
11. Characterization and analysis of human chordoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Choy E; Iafrate J; Rosenberg A; Nielsen GP; Xavier RJ; Mankin H; Duan Z
Spine (Phila Pa 1976); 2010 Jun; 35(13):1257-64. PubMed ID: 20461036
[TBL] [Abstract][Full Text] [Related]
12. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma.
Hao S; Song H; Zhang W; Seldomridge A; Jung J; Giles AJ; Hutchinson MK; Cao X; Colwell N; Lita A; Larion M; Maric D; Abu-Asab M; Quezado M; Kramp T; Camphausen K; Zhuang Z; Gilbert MR; Park DM
Neuro Oncol; 2018 May; 20(6):799-809. PubMed ID: 29294092
[TBL] [Abstract][Full Text] [Related]
14. Comparable Senescence Induction in Three-dimensional Human Cartilage Model by Exposure to Therapeutic Doses of X-rays or C-ions.
Hamdi DH; Chevalier F; Groetz JE; Durantel F; Thuret JY; Mann C; Saintigny Y
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):139-146. PubMed ID: 27084635
[TBL] [Abstract][Full Text] [Related]
15. Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma.
Traylor JI; Sheppard HE; Ravikumar V; Breshears J; Raza SM; Lin CY; Patel SR; DeMonte F
Neurosurgery; 2021 Jan; 88(2):428-436. PubMed ID: 33017025
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines.
Combs SE; Bohl J; Elsasser T; Weber KJ; Schulz-Ertner D; Debus J; Weyrather WK
Int J Radiat Biol; 2009 Feb; 85(2):126-37. PubMed ID: 19280465
[TBL] [Abstract][Full Text] [Related]
17. Assessment of RBE-Weighted Dose Models for Carbon Ion Therapy Toward Modernization of Clinical Practice at HIT: In Vitro, in Vivo, and in Patients.
Mein S; Klein C; Kopp B; Magro G; Harrabi S; Karger CP; Haberer T; Debus J; Abdollahi A; Dokic I; Mairani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):779-791. PubMed ID: 32504659
[TBL] [Abstract][Full Text] [Related]
18. AT cells show dissimilar hypersensitivity to heavy-ion and X-rays irradiation.
Kitajima S; Nakamura H; Adachi M; Ijichi K; Yasui Y; Saito N; Suzuki M; Kurita K; Ishizaki K
J Radiat Res; 2010; 51(3):251-5. PubMed ID: 20197645
[TBL] [Abstract][Full Text] [Related]
19. Synergistic drug combinations and machine learning for drug repurposing in chordoma.
Anderson E; Havener TM; Zorn KM; Foil DH; Lane TR; Capuzzi SJ; Morris D; Hickey AJ; Drewry DH; Ekins S
Sci Rep; 2020 Jul; 10(1):12982. PubMed ID: 32737414
[TBL] [Abstract][Full Text] [Related]
20. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning.
Krämer M; Weyrather WK; Scholz M
Technol Cancer Res Treat; 2003 Oct; 2(5):427-36. PubMed ID: 14529307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
